[go: up one dir, main page]

NO20025151L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20025151L
NO20025151L NO20025151A NO20025151A NO20025151L NO 20025151 L NO20025151 L NO 20025151L NO 20025151 A NO20025151 A NO 20025151A NO 20025151 A NO20025151 A NO 20025151A NO 20025151 L NO20025151 L NO 20025151L
Authority
NO
Norway
Prior art keywords
new connections
polypeptides
polynucleotides
methods
set forth
Prior art date
Application number
NO20025151A
Other languages
English (en)
Other versions
NO20025151D0 (no
Inventor
Pankaj Agarwal
Paul R Murdock
Safia K Rizvi
Randall F Smith
Zhaoying Xiang
Karen S Kabnic
Ying-Ta Lai
Qing Xie
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20025151D0 publication Critical patent/NO20025151D0/no
Publication of NO20025151L publication Critical patent/NO20025151L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)

Abstract

Polypeptider og polynukleotider til genene som er satt fram i tabell I og fremgangsmåter for å produsere slike polypeptider ved rekombinante teknikker blir utgreiet. Fremgangsmåter for å bruke polypeptider og polynukleotider fra genene som er satt fram i tabell I i diagnostisk analyse, blir også utgreiet.
NO20025151A 2000-04-27 2002-10-25 Nye forbindelser NO20025151L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19996300P 2000-04-27 2000-04-27
US20333600P 2000-05-11 2000-05-11
US20708700P 2000-05-25 2000-05-25
US20754600P 2000-05-26 2000-05-26
PCT/US2001/013360 WO2001081363A1 (en) 2000-04-27 2001-04-26 Novel compounds

Publications (2)

Publication Number Publication Date
NO20025151D0 NO20025151D0 (no) 2002-10-25
NO20025151L true NO20025151L (no) 2002-12-13

Family

ID=27498358

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025151A NO20025151L (no) 2000-04-27 2002-10-25 Nye forbindelser

Country Status (15)

Country Link
EP (1) EP1276755A4 (no)
JP (1) JP2003530869A (no)
KR (1) KR20030032940A (no)
CN (1) CN1439017A (no)
AU (1) AU2001257265A1 (no)
BR (1) BR0110402A (no)
CA (1) CA2407449A1 (no)
CZ (1) CZ20023548A3 (no)
HK (1) HK1053840A1 (no)
HU (1) HUP0300595A3 (no)
IL (1) IL152416A0 (no)
MX (1) MXPA02010692A (no)
NO (1) NO20025151L (no)
PL (1) PL358580A1 (no)
WO (1) WO2001081363A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US6558936B1 (en) * 1999-10-01 2003-05-06 Millennium Pharmaceuticals, Inc. Human lipase proteins, nucleic acids encoding them, and uses of both of these
US6630335B1 (en) 2000-02-11 2003-10-07 Millennium Pharmaceuticals, Inc. 14171 protein kinase, a novel human protein kinase and uses thereof
NZ523122A (en) * 2000-06-22 2004-06-25 Smithkline Beecham Corp Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases
JP2004516813A (ja) * 2000-06-30 2004-06-10 インサイト・ゲノミックス・インコーポレイテッド 関連腫瘍マーカー
AU2001288231A1 (en) 2000-08-04 2002-02-18 Zymogenetics Inc. Human secreted protein, zzp1
US20030166526A1 (en) * 2000-08-22 2003-09-04 Challita-Eid Pia M. Nucleic acid and corresponding protein named 158P1H4 useful in the treatment and detection of bladder and other cancers
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
AU1181802A (en) 2000-09-27 2002-04-08 Curagen Corp Novel proteins and nucleic acids encoding same
WO2002026826A2 (en) * 2000-09-27 2002-04-04 Curagen Corporation Proteins and nucleic acids encoding same
CA2430257A1 (en) * 2000-11-28 2002-06-06 Amgen, Inc. Transforming growth factor-beta-related molecules and uses thereof
AU2002252266B2 (en) 2001-03-08 2007-03-29 Immunex Corporation Human serpin polypeptides
US6921807B2 (en) 2001-03-29 2005-07-26 Zymogenetics, Inc. Proteinase inhibitor ZSERP9
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
US20020172995A1 (en) * 2001-05-17 2002-11-21 Wei Shao Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002318513A1 (en) * 2001-07-06 2003-01-21 Nsgene A/S Novel neurotrophic factors
US20030215852A1 (en) * 2002-04-01 2003-11-20 Wyeth Novel pancortin-Pablo protein interactions and methods of use thereof
EP1594892A2 (en) * 2003-02-10 2005-11-16 Agensys, Inc. Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
WO2004069869A1 (ja) * 2003-02-10 2004-08-19 Taisho Pharmaceutical Co., Ltd. アポトーシス誘導遺伝子およびその利用
EP1664106A1 (en) * 2003-08-01 2006-06-07 ZymoGenetics, Inc. Adipocyte complement related protein zacrp11
US7399469B2 (en) * 2004-03-26 2008-07-15 Pdl Biopharma, Inc. Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer
KR102355959B1 (ko) 2012-08-23 2022-01-27 어젠시스 인코포레이티드 158p1d7 단백질에 결합하는 항체 약물 컨쥬게이트(ａｄｃ)
EP3400068A1 (en) * 2016-01-06 2018-11-14 Yeda Research and Development Co., Ltd. Compositions and methods for treating malignant, autoimmune and inflammatory diseases
CN108178797B (zh) * 2017-12-29 2020-12-01 西南大学 一种抗家蚕BmSRC多克隆抗血清、制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830744A (en) * 1995-06-06 1998-11-03 Human Genome Sciences, Inc. Gene encoding human Dnase
JPH09512715A (ja) * 1994-05-05 1997-12-22 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ヒトｄｎａｓｅ
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides

Also Published As

Publication number Publication date
EP1276755A4 (en) 2004-03-31
CA2407449A1 (en) 2001-11-01
HK1053840A1 (zh) 2003-11-07
NO20025151D0 (no) 2002-10-25
CZ20023548A3 (cs) 2003-05-14
CN1439017A (zh) 2003-08-27
IL152416A0 (en) 2003-05-29
PL358580A1 (en) 2004-08-09
WO2001081363A1 (en) 2001-11-01
JP2003530869A (ja) 2003-10-21
AU2001257265A1 (en) 2001-11-07
KR20030032940A (ko) 2003-04-26
HUP0300595A3 (en) 2007-06-28
HUP0300595A2 (hu) 2003-06-28
BR0110402A (pt) 2003-02-11
MXPA02010692A (es) 2003-03-10
EP1276755A1 (en) 2003-01-22

Similar Documents

Publication Publication Date Title
NO20025151L (no) Nye forbindelser
NO20031141L (no) Nye forbindelser
NO20090955L (no) BASB029-polynukleotid(er) og -polypeptider fra Neisseria meningitidis
ATE490466T1 (de) Als interne funktionskontrolle in tests zum nachweis von seltenen zellen verwendete markierte zellen
WO2002002636A3 (en) Membrane associated protein zupari
NO20055634L (no) Fremgangsmate og arkitektur for a aksessere et internettprotokollmedia undersystem (IMS) over et tradlost lokalt nettverk (WLAN)
NO20062201L (no) Fremgangsmater og apparater for soking etter signalbaerere
WO2002090520A3 (en) Toll/interleukin-1 receptor adaptor protein (tirap)
WO2004055491A3 (en) Novel method for sequence determination using nmr
NO20026242D0 (no) Syntesemetoder for aplidin og nye antitumorale derivater, metoder for fremstilling og anvendelse av disse
MXPA03000227A (es) Compuestos novedosos.
DK1651247T3 (da) Behandling og diagnose af neoplasmer ved anvendelse af Thymic Stromal Lymphopoietin
WO2001072961A3 (en) Novel compounds
NO20005952L (no) Antigene polypeptider fra Neisseria Meningitidis, tilsvarende polynukleotider og beskyttende antistoffer
ATE270332T1 (de) Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen
DK1163343T3 (da) Neisseria meningitidis antigene polypeptider, tilsvarende polynukleotider og beskyttende antistoffer
ATE319739T1 (de) Menschliche wingless-änhliche gene
DE602004031355D1 (de) Neue 1,3-disubstituierte azetidinderivate zur verwendung als liganden des 5ht2a-rezeptors
GB2406913A (en) Stimulating and recording device
NO20016340L (no) Hodetraumeindusert cytoplasmatisk kalsiumbindende protein
NO20053511L (no) Nye fibrillin-liknende polypeptider
DK1257573T3 (da) Hidtil ukendt transskriptionsfaktor CARP-2
AU4567300A (en) Novel compounds
ATE443715T1 (de) Polypeptide aus haemophilus influenza
NO20055846L (no) Nye IL-8-liknende polypeptider

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application